Английская Википедия:Bio-Techne
Шаблон:Short description Шаблон:Use mdy dates Шаблон:Other uses Шаблон:Infobox company
Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. The company's brands include R&D Systems, ProteinSimple, and Novus Biologicals.[1]
History
The company was founded in 1976 by Dr. Roger C. Lucas as Research and Diagnostic Systems, Inc. In 1985, it merged into Techne Corporation and became a public company.[1]
In March 2013, Charles (Chuck) Kummeth was named chief executive officer of the company.[2]
In July 2013, the company acquired Bionostics for $104 million.[3][4]
In February 2014, the company changed its name to Bio-Techne.[5]
In April 2014, the company agreed to acquire Shanghai PrimeGene Bio-Tech Company (PrimeGene).[6][7]
In July 2014, the company acquired Novus Biologicals for $60 million.[8][9][10]
In August 2014, the company acquired ProteinSimple for $300 million.[11]
In November 2014, the company agreed to acquire CyVek for $60 million plus up to an additional $135 million in earn-out payments.[12][13][14]
In June 2015, the company agreed to acquire Cliniqa Corporation.[15][16]
In March 2016, the company acquired Zephyrus Biosciences.[17][18][19]
In July 2016, the company acquired Space Import-Export.[20]
In August 2016, company acquired Advanced Cell Diagnostics for $250 million plus an additional $75 million in possible milestone payments.[21][22][23]
In September 2017, the company acquired Trevigen.[24][25]
In January 2018, the company acquired Atlanta Biologicals.[26][27]
In June 2018, the company agreed to acquire Quad Technologies.[28][29]
In August 2018, the company acquired Exosome Diagnostics for $250 million plus up to an additional $325 million in milestone payments.[30]
In June 2019, the company acquired B-Mogen.[31][32]
In April 2021, the company acquired Asuragen for $215 million plus up to an additional $105 million in milestone payments.[33]
In June 2022, the business announced it would acquire Namocell Inc.[34]
In June 2023, Bio-Techne announced it would acquire Lunaphore Technologies SA,[35] the transaction was completed the following month[36]
References
External links
- ↑ 1,0 1,1 Ошибка цитирования Неверный тег
<ref>; для сносок10Kне указан текст - ↑ Шаблон:Cite press release
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite press release
- ↑ Шаблон:Cite press release
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite press release
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite press release
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite press release
- ↑ Шаблон:Cite press release
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite press release
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite press release
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite press release
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite press release
- ↑ Шаблон:Cite press release
- ↑ Шаблон:Cite news
- ↑ Шаблон:Cite press release
- ↑ Шаблон:Cite web
- ↑ https://investors.bio-techne.com/press-releases/detail/373/bio-techne-to-acquire-lunaphore
- ↑ https://www.biospace.com/article/releases/bio-techne-completes-lunaphore-acquisition/?s=79
- Английская Википедия
- 1976 establishments in Minnesota
- Biotechnology companies of the United States
- Companies listed on the Nasdaq
- Technology companies established in 1976
- Страницы, где используется шаблон "Навигационная таблица/Телепорт"
- Страницы с телепортом
- Википедия
- Статья из Википедии
- Статья из Английской Википедии
- Страницы с ошибками в примечаниях
